Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. [electronic resource]
Producer: 20080129Description: 711-7 p. digitalISSN:- 1432-0584
- Acute Disease
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Autoantibodies -- immunology
- Female
- Follow-Up Studies
- Humans
- Immunologic Factors -- administration & dosage
- Male
- Middle Aged
- Platelet Count
- Platelet Membrane Glycoproteins -- immunology
- Purpura, Thrombocytopenic, Idiopathic -- blood
- Remission Induction
- Retrospective Studies
- Rituximab
- Splenectomy
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.